INNATE PHARMA S A
IPHA·45781K204·US·ADR·Healthcare - Biotechnology-13D/G
IPHA (INNATE PHARMA S A) is held by 7 institutional investors as of Q2 2026. Largest holders: MORGAN STANLEY ($80,084), XTX Topco Ltd ($27,839), CITADEL ADVISORS LLC ($22,891). Net institutional sentiment: Mixed.
7
Holders
$161,012
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 16, 2026 · Insiders none · Activists Apr 10, 2026 · Congress none
ActivistNNNovo Nordisk A/S5.0%Apr 10, 2026
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer